Published in Sarcoma on January 01, 2004
Limitations of aspiration cytology in the diagnosis of primary neoplasms. Acta Cytol (1984) 1.44
Cytological diagnosis of bone tumours. J Bone Joint Surg Br (1996) 1.17
Closed vertebral biopsy. J Bone Joint Surg Br (1983) 1.13
Diagnosis of skeletal lymphoma and myeloma by radiology and fine needle aspiration cytology. Cytopathology (2001) 1.09
Cytological diagnosis of skeletal lesions. Fine-needle aspiration biopsy in 110 tumours. J Bone Joint Surg Br (2000) 1.07
Osteosarcoma and the role of fine-needle aspiration. A study of 51 cases. Cancer (1988) 1.04
Fine-needle aspiration biopsy of bone. J Bone Joint Surg Am (1983) 1.03
Fine needle aspiration biopsy of primary bone tumors. Clin Orthop Relat Res (2000) 1.02
Fine-needle aspiration cytology of bone: accuracy and pitfalls of cytodiagnosis. Cancer (2000) 0.97
Closed skeletal needle biopsy: review of 120 cases. AJR Am J Roentgenol (1983) 0.92
Utility of fine-needle aspiration in the diagnosis of primary osteosarcoma. Diagn Cytopathol (2002) 0.92
The importance of the open surgical biopsy in the diagnosis and treatment of bone and soft-tissue tumors. Hematol Oncol Clin North Am (1995) 0.91
The Istituto Rizzoli experience with small cell osteosarcoma. Cancer (1989) 0.84
The role of fine needle aspiration biopsy in the diagnosis and management of osteosarcoma. Pediatr Pathol Mol Med (2001) 0.79
Problems in the interpretation of bone tumors with fine needle aspiration. Acta Cytol (1984) 0.79
Osteosarcoma. Specimen management following primary chemotherapy. Hematol Oncol Clin North Am (1995) 0.79
Osteosarcoma and other cancers of bone. Curr Opin Oncol (1992) 0.78
Histologic subclassification of osteosarcoma: differential diagnostic problems and immunohistochemical aspects. Cancer Treat Res (1993) 0.78
Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts. Breast Cancer Res (2005) 8.73
Sonication of removed hip and knee prostheses for diagnosis of infection. N Engl J Med (2007) 7.82
Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literature. Am J Surg Pathol (2004) 4.46
Novel patterns of genome rearrangement and their association with survival in breast cancer. Genome Res (2006) 4.25
PIK3CA mutations and PTEN loss correlate with similar prognostic factors and are not mutually exclusive in breast cancer. Clin Cancer Res (2007) 3.51
Genotype of metabolic enzymes and the benefit of tamoxifen in postmenopausal breast cancer patients. Breast Cancer Res (2005) 2.48
Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups. J Clin Oncol (2005) 2.17
Clinically used breast cancer markers such as estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 are unstable throughout tumor progression. J Clin Oncol (2012) 2.00
Neoadjuvant chemotherapy for osteosarcoma of the extremity: intensification of preoperative treatment does not increase the rate of good histologic response to the primary tumor or improve the final outcome. J Pediatr Hematol Oncol (2003) 1.99
Postrelapse survival in osteosarcoma of the extremities: prognostic factors for long-term survival. J Clin Oncol (2003) 1.79
Testosterone inhibits estrogen/progestogen-induced breast cell proliferation in postmenopausal women. Menopause (2007) 1.50
Radiographic, CT, and MR imaging features of dedifferentiated chondrosarcomas: a retrospective review of 174 de novo cases. Radiographics (2004) 1.44
Periosteal chondrosarcoma. Orthopedics (2002) 1.43
Diagnosis and grading of chondrosarcomas on FNA biopsy material. Diagn Cytopathol (2003) 1.41
Akt kinases in breast cancer and the results of adjuvant therapy. Breast Cancer Res (2003) 1.41
Primary angiosarcoma of the parotid gland arising from benign congenital hemangioma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2003) 1.40
[Diagnostic problems in hypothyroidism: is increased lymphocyte count in fine needle biopsy an indication for treatment?]. Lakartidningen (2006) 1.40
Histological heterogeneity of Ewing's sarcoma/PNET: an immunohistochemical analysis of 415 genetically confirmed cases with clinical support. Virchows Arch (2009) 1.39
Local recurrence and local control of non-metastatic osteosarcoma of the extremities: a 27-year experience in a single institution. J Surg Oncol (2007) 1.36
The expression of ccn3(nov) gene in musculoskeletal tumors. Am J Pathol (2002) 1.35
Mesenchymal chondrosarcoma. An analysis of patients treated at a single institution. Tumori (2007) 1.31
Immunohistochemistry compared to cytosol assays for determination of estrogen receptor and prediction of the long-term effect of adjuvant tamoxifen. Breast Cancer Res Treat (2010) 1.31
Imaging findings in desmoplastic fibroma of bone: distinctive T2 characteristics. AJR Am J Roentgenol (2005) 1.29
Comprehensive genetic analysis identifies a pathognomonic NAB2/STAT6 fusion gene, nonrandom secondary genomic imbalances, and a characteristic gene expression profile in solitary fibrous tumor. Genes Chromosomes Cancer (2013) 1.29
Clinical potential of the mTOR targets S6K1 and S6K2 in breast cancer. Breast Cancer Res Treat (2010) 1.27
The chimeric FUS/CREB3l2 gene is specific for low-grade fibromyxoid sarcoma. Genes Chromosomes Cancer (2004) 1.24
HER2 status in a population-derived breast cancer cohort: discordances during tumor progression. Breast Cancer Res Treat (2010) 1.20
Prognostic factors in non-metastatic Ewing's sarcoma tumor of bone: an analysis of 579 patients treated at a single institution with adjuvant or neoadjuvant chemotherapy between 1972 and 1998. Acta Oncol (2006) 1.17
Proteinase K added to the extraction procedure markedly increases RNA yield from primary breast tumors for use in microarray studies. Clin Chem (2004) 1.13
Predictive relevance of HOXB13 protein expression for tamoxifen benefit in breast cancer. Breast Cancer Res (2010) 1.12
Genomic profiling of chondrosarcoma: chromosomal patterns in central and peripheral tumors. Clin Cancer Res (2009) 1.12
Grade of chemotherapy-induced necrosis as a predictor of local and systemic control in 881 patients with non-metastatic osteosarcoma of the extremities treated with neoadjuvant chemotherapy in a single institution. Eur J Cancer (2005) 1.10
Distinct histological features characterize primary angiosarcoma of bone. Histopathology (2011) 1.10
Site-specific CGRP innervation coincides with bone formation during fracture healing and modeling: A study in rat angulated tibia. J Orthop Res (2007) 1.10
Activation of Akt, mTOR, and the estrogen receptor as a signature to predict tamoxifen treatment benefit. Breast Cancer Res Treat (2012) 1.10
Dedifferentiated central chondrosarcoma. Cancer (2006) 1.08
Hormone-replacement therapy influences gene expression profiles and is associated with breast-cancer prognosis: a cohort study. BMC Med (2006) 1.08
Neuronal plasticity in relation to nociception and healing of rat achilles tendon. J Orthop Res (2003) 1.07
Primary high-grade osteosarcoma: comparison between preadolescent and older patients. J Pediatr Hematol Oncol (2005) 1.06
Clear cell chondrosarcoma of bone: long time follow-up of 18 cases. Arch Orthop Trauma Surg (2007) 1.06
Surgical treatment of grade I central chondrosarcoma. Clin Orthop Relat Res (2009) 1.06
Radiographic differentiation of enchondroma from low-grade chondrosarcoma in the fibula. Skeletal Radiol (2004) 1.05
Total en bloc spondylectomy of C5 vertebra for chordoma. Spine (Phila Pa 1976) (2007) 1.05
Estrogen receptor-alpha phosphorylation at serine 305, nuclear p21-activated kinase 1 expression, and response to tamoxifen in postmenopausal breast cancer. Clin Cancer Res (2010) 1.05
Metastasizing (malignant) ameloblastoma: review of a unique histopathologic entity and report of Mayo Clinic experience. J Oral Maxillofac Surg (2010) 1.04
Chondroblastoma of the hands and feet. Skeletal Radiol (2004) 1.03
Intact Mre11/Rad50/Nbs1 complex predicts good response to radiotherapy in early breast cancer. Int J Radiat Oncol Biol Phys (2007) 1.03
The BRCA1/BRCA2/Rad51 complex is a prognostic and predictive factor in early breast cancer. Radiother Oncol (2007) 1.03
Late relapse in osteosarcoma. J Pediatr Hematol Oncol (2006) 1.02
Identification of markers of possible prognostic value in 57 giant cell tumors of bone. Oncol Rep (2003) 1.02
Xanthoma of bone: first sign of hyperlipidemia type IIB: a case report. Clin Orthop Relat Res (2003) 1.02
Ratio of 17HSD1 to 17HSD2 protein expression predicts the outcome of tamoxifen treatment in postmenopausal breast cancer patients. Clin Cancer Res (2009) 1.02
Molecular genetic characterization of the EWS/CHN and RBP56/CHN fusion genes in extraskeletal myxoid chondrosarcoma. Genes Chromosomes Cancer (2002) 1.01
Assessment of the clinical and molecular impact of different cytogenetic subgroups in a series of 272 lipomas with abnormal karyotype. Genes Chromosomes Cancer (2007) 1.01
Ezrin in osteosarcoma: comparison between conventional high-grade and central low-grade osteosarcoma. Pathol Res Pract (2006) 1.01
Prognostic and therapeutic relevance of HER2 expression in osteosarcoma and Ewing's sarcoma. Eur J Cancer (2005) 1.01
Insulin-like growth factor type 1 receptor expression correlates to good prognosis in highly malignant soft tissue sarcoma. Clin Cancer Res (2005) 1.00
Role of MMP-9 and its tissue inhibitor TIMP-1 in human osteosarcoma: findings in 42 patients followed for 1-16 years. Acta Orthop Scand (2004) 0.99
Recurrent rearrangement of the PHF1 gene in ossifying fibromyxoid tumors. Am J Pathol (2012) 0.99
Benign bone tumors--recent developments. Semin Diagn Pathol (2011) 0.99
Dedifferentiated chondrosarcomas arising in preexisting osteochondromas. J Bone Joint Surg Am (2007) 0.98
Early nerve regeneration after achilles tendon rupture--a prerequisite for healing? A study in the rat. J Orthop Res (2002) 0.98
Periosteal osteosarcoma: long-term outcome and risk of late recurrence. Clin Orthop Relat Res (2006) 0.98
The mTOR effectors 4EBP1 and S6K2 are frequently coexpressed, and associated with a poor prognosis and endocrine resistance in breast cancer: a retrospective study including patients from the randomised Stockholm tamoxifen trials. Breast Cancer Res (2013) 0.97
Aggressive clear cell chondrosarcomas: do distinctive characteristics exist?: a report of 4 cases. Arch Pathol Lab Med (2006) 0.96
Primary diffuse meningeal melanomatosis: radiologic-pathologic correlation. AJNR Am J Neuroradiol (2003) 0.96
Mesenchymal stromal cells from primary osteosarcoma are non-malignant and strikingly similar to their bone marrow counterparts. Int J Cancer (2010) 0.96
Evaluation of P-glycoprotein, HER-2/ErbB-2, p53, and Bcl-2 in primary tumor and metachronous lung metastases in patients with high-grade osteosarcoma. Cancer (2004) 0.96
Epithelioid variant of myxofibrosarcoma: expanding the clinicomorphologic spectrum of myxofibrosarcoma in a series of 17 cases. Am J Surg Pathol (2007) 0.96
Activated ERK1/2 and phosphorylated oestrogen receptor alpha are associated with improved breast cancer survival in women treated with tamoxifen. Eur J Cancer (2006) 0.95
Increased osteoclast activity is associated with aggressiveness of osteosarcoma. Int J Oncol (2008) 0.94
Amplification of HSD17B1 and ERBB2 in primary breast cancer. Oncogene (2003) 0.94
Dedifferentiation in low-grade mucoepidermoid carcinoma of the parotid gland. Hum Pathol (2003) 0.94
Chondrosarcoma of the chest wall: a clinical analysis. Surg Today (2002) 0.94
Fusion, disruption, and expression of HMGA2 in bone and soft tissue chondromas. Mod Pathol (2003) 0.94
Primary schwannoma of the bone: a clinicopathologic and radiologic study of 17 cases. Am J Surg Pathol (2011) 0.93
Results of the Scandinavian Sarcoma Group XIV protocol for classical osteosarcoma: 63 patients with a minimum follow-up of 4 years. Acta Orthop (2011) 0.92
Severe suppression of Frzb/sFRP3 transcription in osteogenic sarcoma. Gene (2006) 0.92
Dedifferentiated peripheral chondrosarcomas: regulation of EXT-downstream molecules and differentiation-related genes. Mod Pathol (2009) 0.91
Alteration in endogenous opioid systems due to chronic inflammatory pain conditions. Eur J Pharmacol (2002) 0.91
Cytoplasmic p21WAF1/CIP1 correlates with Akt activation and poor response to tamoxifen in breast cancer. Int J Oncol (2006) 0.91
C-kit receptor expression in Ewing's sarcoma: lack of prognostic value but therapeutic targeting opportunities in appropriate conditions. J Clin Oncol (2003) 0.91
The role of surgical margins in treatment of Ewing's sarcoma family tumors: experience of a single institution with 512 patients treated with adjuvant and neoadjuvant chemotherapy. Int J Radiat Oncol Biol Phys (2006) 0.91
The value of preoperative grade of radiographic and histological changes in predicting pain relief after total knee arthroplasty for osteoarthritis. Knee Surg Sports Traumatol Arthrosc (2011) 0.91
Multicentric osteosarcoma: clinicopathologic and radiographic study of 56 cases. Am J Clin Pathol (2011) 0.90
Predictive factors of histologic response to primary chemotherapy in patients with Ewing sarcoma. J Pediatr Hematol Oncol (2007) 0.90
Multimodal therapy for the treatment of nonmetastatic Ewing sarcoma of pelvis. J Pediatr Hematol Oncol (2003) 0.90
Primary angiosarcoma of bone: a retrospective analysis of 60 patients from 2 institutions. Am J Clin Oncol (2014) 0.90
Expression of heat shock proteins in osteosarcomas. Pathology (2010) 0.90
Occupational factors and risk of adult bone sarcomas: a multicentric case-control study in Europe. Int J Cancer (2006) 0.89
Value of P-glycoprotein and clinicopathologic factors as the basis for new treatment strategies in high-grade osteosarcoma of the extremities. J Clin Oncol (2003) 0.89
A prospective comparison of fine-needle aspiration cytology and histopathology in the diagnosis and classification of lymphomas. Hematol J (2004) 0.89
Small cell osteosarcoma: clinicopathologic, immunohistochemical, and molecular analysis of 36 cases. Am J Surg Pathol (2015) 0.89
Fine-needle aspiration cytology and immunocytochemistry of orbital masses. Diagn Cytopathol (2006) 0.88